Health

One year after Omicron, how is the world coping with coronavirus?
Health

One year after Omicron, how is the world coping with coronavirus?

It is barely more than a year since scientists in southern Africa first detected the coronavirus Omicron variant, which, along with its myriad sub-variants, went on to become dominant around the globe. Omicron spreads more easily than earlier variants, but causes less severe illness and death in general, statistics have shown. However, a surge in cases may lead to increases in admissions to hospital and deaths. Omicron caused Covid-19 infection and death rates to soar in many nations. But, 12 months months on, the latest figures from the World Health Organisation indicate that the disease is causing a little more than 8,000 deaths a week worldwide — the lowest figure since March 2020, when the pandemic was declared by the WHO. In 2021, there was no single week when fewer than 40,000 ...
Novartis and MMV to advance new malaria drug combination to phase 3 study
Health

Novartis and MMV to advance new malaria drug combination to phase 3 study

Novartis and Medicines for Malaria Venture (MMV) have announced the decision to advance novel drug combination ganaplacide/lumefantrine into phase 3 development for the treatment of patients with acute uncomplicated malaria due to Plasmodium falciparum. The announcement comes as the threat of resistance to current malaria treatments grows, underpinning a need for new medicines to continue the fight toward the elimination of malaria. Plasmodium falciparum malaria – one of the two malaria parasites the World Health Organization cites as posing the greatest threat – is primarily treated with artemisinin-based combination therapies such as artemether-lumefantrine. Artemisinin-based combination therapies are still highly effective and well tolerated, however, the increased frequency by whi...
Nearly 40 million children are dangerously susceptible to growing measles threat
Health

Nearly 40 million children are dangerously susceptible to growing measles threat

Measles vaccination coverage has steadily declined since the beginning of the COVID-19 pandemic. In 2021, a record high of nearly 40 million children missed a measles vaccine dose: 25 million children missed their first dose and an additional 14.7 million children missed their second dose, a joint publication by the World Health Organization (WHO) and the United States Centers for Disease Control and Prevention (CDC) reports. This decline is a significant setback in global progress towards achieving and maintaining measles elimination and leaves millions of children susceptible to infection. In 2021, there were an estimated 9 million cases and 128 000 deaths from measles worldwide. Twenty-two countries experienced large and disruptive outbreaks. Declines in vaccine coverage, weakened me...